.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,087,697

« Back to Dashboard

Details for Patent: 5,087,697

Title: Therapeutic nucleosides
Abstract:The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. The invention also relates to pharmaceutical formulations and processes for the preparation of compounds according to the invention.
Inventor(s): Daluge; Susan M. (Chapel Hill, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Filing Date:Dec 19, 1990
Application Number:07/630,129
Claims:1. Enantiomeric compounds of formula (III) ##STR14## wherein A represents the 2-cyclopentene-1-methanol-4-yl group in either the (1S,4R) or (1R,4S) configuration, R represents a cyclopropylamino or N-cyclopropyl-N-methylamino group, R.sup.2 represents hydrogen or a formyl group and R.sup.3 represents a C.sub.1-6 alkanoyl group, or a salt or ester thereof.

2. Enantiomeric compounds of formula (V) ##STR15## wherein A represents the 2-cyclopentene-1-methanol-4-yl group in either the (1S,4R) or (1R,4S) configuration, Z represents a halo group, R.sup.2 represents hydrogen or a formyl group and R.sup.3 represents a C.sub.1-6 alkanoyl group, or a salt or ester thereof.

3. (1R,4S)-cis-N-[4-Chloro-5-formamido-6-((4 -(hydroxymethyl)-2-cyclopentene-1-yl)amino)-2-pyrimidinyl]isobutyramide substantially free of the corresponding (1S,4R) enantiomer.

4. Compounds of formula (VII) ##STR16## wherein Z represents a halo group, R.sup.2 represents hydrogen or a formyl group, R.sup.3 represents a C.sub.1-6 alkanoyl group and R.sup.4 represents a halo group, or a salt thereof.

5. N-(4,6-Dichloro-5-formamido-2-pyrimidinyl)isobutyramide.

6. Compounds of formula (IX) ##STR17## wherein Z represents a halo group, R.sup.3 represents a C.sub.1-6 alkanoyl group and R.sup.4 represents a halo group or a salt thereof.

7. N-(4,6-Dichloro-5-nitro-2-pyrimidinyl)isobutyramide.

8. Compounds of formula (X) ##STR18## wherein R.sup.3 represents a C.sub.1-6 alkanoyl group and R.sup.4 represents a halo group or a salt thereof.

9. N-(4-Chloro-1,6-dihydro-5-nitro-6-oxo-2-pyrimidinyl)isobutyramide.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc